Hepatocyte Growth Factor Activator Inhibitor Type1 (HAI-1) Human ELISA
| Other names: | HAI-1 | ||
|---|---|---|---|
| Cat. No.: | RSC27405R | Regulatory status: RUO | |
| Size: | 96 wells (1 kit) | | | |
| Files: | Datasheet PDF (RUO) | ||
| Legend: |  new product discount |
 temporarily out of stock order in advance |
|
Research topic
Cytokines and chemokines and related molecules
Storage/Shipping
+4°C/ Wet ice
Summary
HAI-1 is one of two types of Kunitz-type serine protease inhibitors that was detected as an inhibitory factor of hepatocyte growth factor activator (HGFA), the factor that converts hepatocyte growth factor into the active form. It is said to act as a transmembrane protein having two Kunitz domains, and to inhibit HGFA also as a free form secreted from membrane. HAI-1 targets various other serine proteases such as matriptase and hepsin. It has been detected in the placenta, kidney, pancreas, prostate, and small intestine, and also reported to express in the liver cancer.
Assay format
Sandwich ELISA, HRP-labelled antibody
Sample requirements
25 µl/well
Applications
Cell culture medium, Plasma-EDTA, Serum
Calibration Curve
|
Calibration range
39.06 to 2 500 pg/ml
Limit of detection
16.98 pg/ml
Limit of quantification
16.98 pg/ml
Shopping cart
Your cart is empty.